Annika Dwucet

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

Marc‐Eric Halatsch, Richard E. Kast, Georg Karpel‐Massler et al. · Neuro-Oncology Advances · 2021 · 65 citations · Full text

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect

Georg Karpel‐Massler, Richard E. Kast, Mike‐Andrew Westhoff et al. · Journal of Neuro-Oncology · 2014 · 59 citations

Antiproliferative Effect, Medicine, Pharmacological Agent +9

Combined Inhibition of HER1/EGFR and RAC1 Results in a Synergistic Antiproliferative Effect on Established and Primary Cultured Human Glioblastoma Cells

Georg Karpel‐Massler, Mike‐Andrew Westhoff, Shaoxia Zhou et al. · Molecular Cancer Therapeutics · 2013 · 54 citations

Glial Origin, High-grade Gliomas, Cancer Biology +17

Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma

Maximilian Pruss, Annika Dwucet, Mine Tanriover et al. · British Journal of Cancer · 2020 · 53 citations · Full text

Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines

Georg Karpel‐Massler, Mike‐Andrew Westhoff, Richard E. Kast et al. · Anti-Cancer Agents in Medicinal Chemistry · 2014 · 40 citations